ACET.NASDAQ | Adicet Bio Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.359 | 0.392 | 154.7k | $360.1k | $140.4k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
ALT.NASDAQ | Altimmune Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.666 | 0.811 | 473.8k | $888.4k | $3.2m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
AMLX.NASDAQ | Amylyx Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.434 | 1.433 | 295k | $844.2k | $1m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
AUPH.NASDAQ | Aurinia Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.697 | 1.73 | 997.2k | $2.6m | $7.9m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 6/10 | 60.0% | | Total | 6/10 | 60.0% | |
---|
| |
AUTL.NASDAQ | Autolus Therapeutics Ltd | USA | Healthcare | Biotechnology | 2024-09-30 | 0.448 | 1.202 | 1.1m | $2.1m | $2.6m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
AVDL.NASDAQ | Avadel Pharmaceuticals PLC | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-09-30 | 0.083 | 0.036 | 50k | $38.7k | $387.5k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
BDTX.NASDAQ | Black Diamond Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.085 | 0.023 | 44k | $75.7k | $96.8k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
CCCC.NASDAQ | C4 Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.585 | 0.569 | 405.8k | $1.3m | $1.5m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
CNCE.NASDAQ | CNCE.NASDAQ | - | - | - | - | 0.418 | 0.333 | 200.8k | - | - | | |
CRBP.NASDAQ | Corbus Pharmaceuticals Holding | USA | Healthcare | Biotechnology | 2024-09-30 | 0.257 | 0.18 | 31.2k | $386.7k | $373k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
CRBU.NASDAQ | Caribou Biosciences Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.292 | 0.46 | 257.8k | $800.7k | $394.5k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
DYN.NASDAQ | Dyne Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.051 | 2.107 | 641k | $4.4m | $9m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
ERAS.NASDAQ | Erasca Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.705 | 1.231 | 1.9m | $3m | $3.5m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
EYPT.NASDAQ | Eyepoint Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.369 | 0.37 | 180k | $576.9k | $1.3m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
FULC.NASDAQ | Fulcrum Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.313 | 0.4 | 193.7k | $798.7k | $767.2k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
GLPG.NASDAQ | Galapagos NV ADR | USA | Healthcare | Biotechnology | 2024-09-30 | 0.187 | 1.646 | 123.3k | $5.5m | $2.9m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
GMAB.NASDAQ | Genmab AS | USA | Healthcare | Biotechnology | 2024-09-30 | 0.038 | 2.132 | 242.3k | $1.6m | $5m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 6/10 | 60.0% | | Total | 6/10 | 60.0% | |
---|
| |
GMDA.NASDAQ | GMDA.NASDAQ | - | - | - | - | 0.144 | 0.055 | 107k | - | - | | |
GRFS.NASDAQ | Grifols SA ADR | USA | Healthcare | Drug Manufacturers - General | 2024-09-30 | 0.114 | 1.913 | 773k | $9.3m | $5.6m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
HRMY.NASDAQ | Harmony Biosciences Holdings | USA | Healthcare | Biotechnology | 2024-09-30 | 0.537 | 3.279 | 314.5k | $3.2m | $12.2m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 7/10 | 70.0% | | Total | 7/10 | 70.0% | |
---|
| |
IMAB.NASDAQ | I-Mab | USA | Healthcare | Biotechnology | 2024-09-30 | 0.384 | 0.156 | 310.4k | $874.9k | $332.2k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
KALV.NASDAQ | Kalvista Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-10-31 | 0.873 | 1.391 | 431.2k | $1.1m | $3.5m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
KDNY.NASDAQ | KDNY.NASDAQ | - | - | - | - | 0.474 | 2.532 | 340.3k | - | - | | |
KZR.NASDAQ | Kezar Life Sciences Inc | USA | | | 2024-09-30 | 4.802 | 0.065 | 350.3k | $643.6k | $2.2m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
MRNS.NASDAQ | Marinus Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.525 | 0.141 | 290k | -$338.1k | $156.6k | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
QURE.NASDAQ | Uniqure NV | USA | Healthcare | Biotechnology | 2024-09-30 | 3.013 | 2.013 | 1.4m | $1.5m | $20.6m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
RSLS.NASDAQ | ReShape Lifesciences Inc | USA | Healthcare | Medical Devices | 2024-09-30 | 0 | 0 | 1.00 | $2.09 | $4.86 | Scanner | Score | % | |
---|
Penke's Stock Scanner | 2/10 | 20.0% | | Total | 2/10 | 20.0% | |
---|
| |
SUPN.NASDAQ | Supernus Pharmaceuticals Inc | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-09-30 | 0.929 | 4.456 | 513k | $9.2m | $19.3m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 7/10 | 70.0% | | Total | 7/10 | 70.0% | |
---|
| |
TERN.NASDAQ | Terns Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.302 | 0.527 | 254.6k | $1m | $1.1m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
TVTX.NASDAQ | Travere Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.735 | 3.331 | 639.6k | -$223.8k | $11.7m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 3/10 | 30.0% | | Total | 3/10 | 30.0% | |
---|
| |
VERA.NASDAQ | Vera Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.766 | 6.676 | 485.1k | $2.2m | $16.1m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 4/10 | 40.0% | | Total | 4/10 | 40.0% | |
---|
| |
VNDA.NASDAQ | Vanda Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.78 | 1.354 | 1m | $9.6m | $4.5m | Scanner | Score | % | |
---|
Penke's Stock Scanner | 5/10 | 50.0% | | Total | 5/10 | 50.0% | |
---|
| |
ZGNX.NASDAQ | ZGNX.NASDAQ | - | - | - | - | 0.24 | 0.516 | 135k | - | - | | |